Black Diamond Therapeutics, Inc.
BDTX
$2.02
$0.000.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -100.00% | -100.00% | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -100.00% | -100.00% | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -100.00% | -100.00% | -- | -- | -- |
| SG&A Expenses | -18.92% | -38.35% | -39.67% | -31.32% | -31.79% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -31.76% | -37.95% | -36.37% | -28.54% | -25.16% |
| Operating Income | -1,046.99% | -1,046.54% | 125.22% | 114.57% | 105.39% |
| Income Before Tax | -394.72% | -948.77% | 132.10% | 129.41% | 117.93% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -394.72% | -948.77% | 132.10% | 129.41% | 117.93% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -394.72% | -948.77% | 132.10% | 129.41% | 117.93% |
| EBIT | -1,046.99% | -1,046.54% | 125.22% | 114.57% | 105.39% |
| EBITDA | -978.37% | -1,147.04% | 125.75% | 115.06% | 105.81% |
| EPS Basic | -392.84% | -1,056.94% | 131.32% | 127.88% | 116.51% |
| Normalized Basic EPS | -356.20% | -1,051.57% | 140.27% | 126.30% | 115.34% |
| EPS Diluted | -428.43% | -1,451.24% | 129.42% | 126.13% | 114.78% |
| Normalized Diluted EPS | -376.34% | -1,394.75% | 138.92% | 125.04% | 114.22% |
| Average Basic Shares Outstanding | 0.90% | 1.39% | 3.37% | 5.53% | 8.13% |
| Average Diluted Shares Outstanding | 0.45% | 0.94% | 3.82% | 6.00% | 8.61% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |